With reference to its disclosure made by the Company on July 3, 2023 regarding acquisition of certain marketing and manufacturing related authorisations. Aurobindo Pharma has informed updates regarding the aforesaid disclosure are attached as 'Annexure - I' to this disclosure.
The above information is a part of company’s filings submitted to BSE.